Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Clinical trial NCT07542912 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07542912
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Complete Remission Rate， CRR Progression Free Survival Overall Survival Adverse Event Duration of Response

Start date: 2026-06-01
Primary completion: 2029-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.